Detalhe da pesquisa
1.
A retrospective study of treosulfan versus busulfan-based conditioning in pediatric patients.
Eur J Haematol
; 109(5): 474-482, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35810360
2.
Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
Ann Hematol
; 100(3): 779-787, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33515310
3.
Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity.
Pediatr Hematol Oncol
; 38(4): 331-345, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33661711
4.
COVID-19 in pediatric hematopoietic stem cell transplantation: The experience of Spanish Group of Transplant (GETMON/GETH).
Pediatr Blood Cancer
; 67(9): e28514, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32573924
5.
Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic.
Pediatr Blood Cancer
; 67(9): e28557, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32672895
6.
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy.
Transplant Cell Ther
; 29(7): 430-437, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031746